Navigation Links
Helix BioPharma Corp. Announces Fiscal 2009 Results
Date:10/29/2009

s totalled $18,000 in fiscal 2009 and $153,000 in fiscal 2008. Income taxes are attributable to the Company's operations in Ireland.

LIQUIDITY AND CAPITAL RESOURCES

Since inception, the Company has financed its operations from public and private sales of equity, the exercise of warrants and stock options, and, to a lesser extent, on interest income from funds available for investment, investment tax credits, and revenues from distribution, licensing and contract services. Since the Company does not have net earnings from its operations, the Company's long-term liquidity depends on its ability to access the capital markets, which depends substantially on the success of the Company's ongoing research and development programs.

At July 31, 2009 and 2008, the Company had cash and cash equivalents totaling $14,494,000 and $19,057,000, respectively. The $4,563,000 decrease in cash and cash equivalents reflects a use of cash in operating activities of $13,157,000 which includes a net loss for the year of $14,102,000. Operating activities were financed from a private placement which closed on October 2, 2008 for net proceeds of $9,659,000. Cash used in investing activities in the 2009 fiscal year total $932,000 which predominately reflects purchases of research and development equipment. Effect of exchange rate changes on cash and cash equivalents in fiscal 2009 represent a foreign exchange loss of $133,000.

At July 31, 2009 and 2008, the Company's working capital was $15,296,000 and $19,166,000, respectively.

On September 8, 2009, subsequent to Company's fiscal year ended July 31, 2009, the Company completed an additional private placement, issuing 6,625,000 units at $2.05 per unit, for gross proceeds of $13,581,250. Each unit consists of one common share and one common share purchase warrant, with each common share purchase warrant entitling the holder to purchase, subject to adjustment, one common share
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
7. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
8. PDL BioPharma Completes October 1 Special Dividend Payment
9. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 Endo International plc (NASDAQ: ... revenues of $719 million, an increase of 1 percent ... Endo reported net income of $21 million in the ... million in the second quarter of 2013.  As detailed ... for the three months ended June 30, 2014 increased by ...
(Date:7/31/2014)... , 2014 Second Quarter Total Revenue $2.0 billion; an ... growth was 4% for same store sales and 8% pro ... 12% , 2014 Second Quarter GAAP EPS $0.37; Cash ... Quarter GAAP Operating Cash Flow $376 million; Adjusted Operating Cash ... Quarter , Launched 17 new products in the U.S. year-to-date ...
(Date:7/31/2014)... -- Today,s Consumer Reports story on prescription and non-prescription ... consumers of the importance of taking medicines safely ... the Acetaminophen Awareness Coalition,s (AAC) Know ... in 2010, the Coalition is a group of ... to educating consumers on safe acetaminophen use to ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5
... 2011 Ventana Medical Systems, Inc . (Ventana), ... first-of-its-kind integration of the VIRTUOSO digital pathology software and ... integration to the anatomic pathology lab. The ... track the progress of a slide from preparation to ...
... 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... manufacturer and marketer of orthopedic implants in China, today announced ... Bank of America Merrill Lynch New China Conference to be ... JW Marriot Hotel in Beijing, China.  Management is scheduled to ...
Cached Medicine Technology:Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 2Ventana Medical Systems, Inc. Introduces Groundbreaking Laboratory Workflow Integration 3China Kanghui Holdings Announces Participation in Upcoming Investor Conferences 2
(Date:7/31/2014)... ProtonPACS, a division of Radsource, has ... Rural Health Association (NRHA), company officials announced today. The ... needs of rural health providers nationwide. , “We are ... said Dr. Mark Awh, President of Radsource. “While we ... we are also looking forward to learning from all ...
(Date:7/31/2014)... Boston, MA (PRWEB) July 31, 2014 Many ... fight for the weak, to correct injustices, and preserve the ... - action that can be lauded as crusading and exemplary ... the lawyer takes on corruption whose seed might be planted ... a fury and the ultimate punishment for an attorney - ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Computer Resources ... firm based in New York City, has been awarded ... the midtown Manhattan headquarters of a large global bank. ... investment banking. , Chico Ramnarayan, Chief Executive Officer of ... is an opportunity for us to further develop what ...
(Date:7/31/2014)... Loffler Companies, the leading business technology and ... Microsoft as a Microsoft Community Connections Partner of the ... 14, 2014. , The Microsoft U.S. SMB Champions ... cloud-based IT services and solutions to small and midsized ... SMB Champions Club member, Loffler has established a proven ...
(Date:7/31/2014)... 31, 2014 According to new ... Wheat, Mycoprotein), by Type (Tofu, Tofu-Based Product, Tempeh, ... - Global Trends & Forecasts to 2019", defines ... an analysis and forecasting of the market value ... The report also identifies the driving and restraining ...
Breaking Medicine News(10 mins):Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 2Health News:Supreme Court Press Petition of the Month for July 2014: Shutting Down Inconvenient Lawyers By Disbarment or Suspension 3Health News:Global Bank Awards CRA with Network Infrastructure Contract 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 2Health News:Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3
... by researchers at Wake Forest University Baptist Medical Center is ... weight loss in older adults leads to increased risk of ... intentionally exercised and/or modified their diets to lose weight were ... as their peers who did not work toward weight loss, ...
... give into your child,s meltdowns, expert says , SUNDAY, April ... have a hard time figuring out what to do when ... that kids often have their meltdowns in public places -- ... a Kansas State University child development expert, has compiled tips ...
... or more a week often quit their own jobs, researchers say ... more than 60 hours a week, watch out: His commitment ... , A new study finds that women with husbands who work ... expected to pick up the slack at home in regard to ...
... The law firm of Dussault ... $90,000.00 , ... 2, 2010 -- The law firm of Dussault and Zatir settled out of court a claim ... 92-year-old woman, while walking in her yard, was knocked to the ground by a neighbor’s dog. ...
... ... ... Passover and Easter, a New Jersey physician ventured into the bush country of Haiti. , ... N.J. resident, left at 4 a.m. on Friday, April 2, for a week-long medical mission ...
... tie-in to tremors and other motor problems , ... how a mutation in a gene called LRRK2 may ... , In experiments using genetically engineered mice, the Mount ... dopamine transmission and controls motor performance. Dopamine is a ...
Cached Medicine News:Health News:Belief that intentional weight loss is harmful to seniors is unfounded 2Health News:Belief that intentional weight loss is harmful to seniors is unfounded 3Health News:Dealing With Those All-Too-Public Tantrums 2Health News:Working Wives Still Expected to Do It All, Study Finds 2Health News:NJ Medical Director Travels To Haiti's Bush Country 2Health News:NJ Medical Director Travels To Haiti's Bush Country 3
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
... This remarkable anti-reflux valve is ... housing which prevents the valve ... when in sitting or reclining ... self-cleaning and interference free ensuring ...
... AggRAM, for platelet aggregation and ristocetin ... with the power of Windows-based software ... to two AggRAM modules can be ... computer so you can configure your ...
The Multiple Perfusion set provides simultaneous perfusion of the aortic root and up to three or more vein grafts. The set features an inlet port with female luer and clamp attached to an adapter whi...
Medicine Products: